234 related articles for article (PubMed ID: 8077388)
1. Enzyme immunoassay using native envelope glycoprotein (gp160) for detection of human immunodeficiency virus type 1 antibodies.
Nair BC; Ford G; Kalyanaraman VS; Zafari M; Fang C; Sarngadharan MG
J Clin Microbiol; 1994 Jun; 32(6):1449-56. PubMed ID: 8077388
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic value of antibodies against HIV-1 proteins in seropositive drug addicts tested by the western blotting method].
Swiderska H; Kalinowska B
Przegl Epidemiol; 1992; 46(1-2):19-25. PubMed ID: 1475386
[TBL] [Abstract][Full Text] [Related]
3. Reliable confirmation and quantitation of human immunodeficiency virus type 1 antibody using a recombinant-antigen immunoblot assay.
Busch MP; el Amad Z; McHugh TM; Chien D; Polito AJ
Transfusion; 1991 Feb; 31(2):129-37. PubMed ID: 1899951
[TBL] [Abstract][Full Text] [Related]
4. Characterization of serum antibody responses to recombinant HIV-1 gp160 vaccine by enzyme immunoassay. NIAID AIDS Vaccine Clinical Trials Network.
Viscidi R; Ellerbeck E; Garrison L; Midthun K; Clements ML; Clayman B; Fernie B; Smith G
AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1251-6. PubMed ID: 1706607
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.
Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A
Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590
[TBL] [Abstract][Full Text] [Related]
6. Reactivity of a new HIV-1 group O third generation A-HIV-1/-2 assay with an unusual HIV-1 seroconversion panel and HIV-1 group O/group M subtyped samples.
van Binsbergen J; Keur W; vd Graaf M; Siebelink A; Jacobs A; de Rijk D; Toonen J; Zekeng L; Afane Ze E; Gürtler LG
J Virol Methods; 1997 Dec; 69(1-2):29-37. PubMed ID: 9504748
[TBL] [Abstract][Full Text] [Related]
7. Performance characteristics of recombinant enzyme immunoassay to detect antibodies to human immunodeficiency virus type 1 (HIV-1) and HIV-2 and to measure early antibody responses in seroconverting patients.
Galli RA; Castriciano S; Fearon M; Major C; Choi KW; Mahony J; Chernesky M
J Clin Microbiol; 1996 Apr; 34(4):999-1002. PubMed ID: 8815130
[TBL] [Abstract][Full Text] [Related]
8. Early and specific diagnosis of seropositivity to HIVs by an enzyme-linked immunosorbent assay using env-derived synthetic peptides.
Fenouillet E; Sorensen AM; Lacroix M; Coutellier A; Herson S; Fretz-Foucault C; Gluckman JC
AIDS; 1990 Nov; 4(11):1137-40. PubMed ID: 2282186
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of human immunodeficiency virus type 1 antibody reactivity by western immunoblots: evaluation of relative antibody levels in seropositive individuals and mothers.
Geffin RB; Lai SH; Hutto C; Scott GB; Scott WA; Master M; Parks WP
J Infect Dis; 1992 Jan; 165(1):111-8. PubMed ID: 1727880
[TBL] [Abstract][Full Text] [Related]
10. Detection of binding antibodies to native and recombinant human immunodeficiency virus type 1 envelope glycoproteins following recombinant gp160 immunization measured by flow cytometry and enzyme immunoassays. The AIDS Vaccine Clinical Trials Network.
Gorse GJ; Frey SE; Newman FK; Belshe RB
J Clin Microbiol; 1992 Oct; 30(10):2606-12. PubMed ID: 1400960
[TBL] [Abstract][Full Text] [Related]
11. False-positive human immunodeficiency virus type 1 western blot tests in noninfected blood donors.
Sayre KR; Dodd RY; Tegtmeier G; Layug L; Alexander SS; Busch MP
Transfusion; 1996 Jan; 36(1):45-52. PubMed ID: 8607152
[TBL] [Abstract][Full Text] [Related]
12. Strongly enhanced sensitivity of a direct anti-HIV-1/-2 assay in seroconversion by incorporation of HIV p24 ag detection: a new generation vironostika HIV Uni-Form II.
van Binsbergen J; Keur W; Siebelink A; van de Graaf M; Jacobs A; de Rijk D; Nijholt L; Toonen J; Gürtler LG
J Virol Methods; 1998 Dec; 76(1-2):59-71. PubMed ID: 9923740
[TBL] [Abstract][Full Text] [Related]
13. Gp160 of commercial HIV western blots is not gp160env. Should criteria for seropositivity be revised?
Fenouillet E; Blanes N; Gluckman JC
AIDS; 1991 Jun; 5(6):770. PubMed ID: 1883550
[No Abstract] [Full Text] [Related]
14. Radioimmune western blotting in comparison with conventional western blotting, second and third generation ELISA assays for the serodiagnosis of HIV-1 infection.
Portincasa P; Conti G; Zannino T; Visalli S; Chezzi C
New Microbiol; 1994 Jul; 17(3):169-76. PubMed ID: 7968651
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 neutralizing antibodies in urine from seropositive individuals.
Cao YZ; Friedman-Kien AE; Mirabile M; Li XL; Alam M; Dieterich D; Ho DD
J Acquir Immune Defic Syndr (1988); 1990; 3(3):195-9. PubMed ID: 1968094
[TBL] [Abstract][Full Text] [Related]
16. Blocking-ELISA for detection of specific antibodies to the glycoproteins of the human immunodeficiency virus type 1 (HIV-1).
Tardy JC; Basson J; Douglas A; Aymard M
J Med Virol; 1990 Mar; 30(3):206-10. PubMed ID: 2187949
[TBL] [Abstract][Full Text] [Related]
17. Significance of the positivity of some ELISA tests different as concerning the antigenic source in interpreting the western blot indeterminate sera in monitoring the epidemiology of high risk populations.
Neguţ E; Mazilu E; Băncescu G
Roum Arch Microbiol Immunol; 1992; 51(1-2):101-13. PubMed ID: 1457820
[TBL] [Abstract][Full Text] [Related]
18. Specific western blot bands are associated with initial CD4+ lymphocyte counts in human immunodeficiency virus seroconverters. The Navy HIV Working Group.
Garland FC; Garland CF; Gorham ED; Brodine SK; Weiss PJ
Ann Epidemiol; 1994 Jan; 4(1):27-31. PubMed ID: 7911377
[TBL] [Abstract][Full Text] [Related]
19. Envelope cross-reactivity between human immunodeficiency virus types 1 and 2 detected by different serological methods: correlation between cross-neutralization and reactivity against the main neutralizing site.
Böttiger B; Karlsson A; Andreasson PA; Nauclér A; Costa CM; Norrby E; Biberfeld G
J Virol; 1990 Jul; 64(7):3492-9. PubMed ID: 2191152
[TBL] [Abstract][Full Text] [Related]
20. Apparent HIV-1 glycoprotein reactivity on western blot in uninfected blood donors.
Healey DS; Bolton WV
AIDS; 1993 May; 7(5):655-8. PubMed ID: 8318173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
